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average age was 54 years (standard deviation  11 years, range 17-85 years) with
the majority being female (78%), white (87%), having a some college education or
more (73%) and having health insurance (87%). Approximately 58% of patients
reported medication nonadherence. No significant differences were observed be-
tween adherent and nonadherent patients with regard to age, sex, race, insurance
status, condition, or number of medications taken. Reasons significantly associ-
ated with nonadherence were forgetting, don’t like to take pills/give injection, cost
of medication, symptoms improved so stopped taking medication, side effects too
severe, and poor knowledgeable about their medications. CONCLUSIONS: Medica-
tion nonadherence is common and patient reported reasons for nonadherence
include motivational factors, lack of understanding or knowledge, and treatment-
related characteristics. Interventions that motivate, educate and individualize
drug therapy according to patients’ preferences and affordability may improve
adherence.
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OBJECTIVES: The EQ-5D has been extensively used to assess health-related quality
of life (HRQoL) and utility across different health condition worldwide. The aim of
this study was to systematically review studies using EQ-5D in the Brazilian
population. METHODS: A structured literature search was conducted using free
text words related to EQ-5D and Brazil in Pubmed and LILACS database. Original
research studies that reported EQ-5D results among Brazilian patients or general
population were included. RESULTS: Of 23 identified papers (Pubmed11, LI-
LACS12, 3 duplicate citations), 4 met the selection criteria, with one study report-
ing evidence on validity for stroke patients (Pinto 2011), one study reporting EQ-5D
responses (index, VAS and self-classification) for caregivers of stroke patients
(Carod-Artal 2009) and two publications of the same SF-6D study for rheumatoid
arthritis (RA) patients in which EQ-5D was used as a comparison measure (Cam-
polina 2009 and 2010). All 3 studies reported EQ-5D index, 2 of them used the UK
tariff and Carod-Artal 2009 did not inform the conversion method. Mean EQ-5D
index scores were 0.65 (SD 0.3) for RA patients and 0.7 (SD 0.2) for caregivers of
stroke patients. The study which applied EQ-5D to stroke patients did not report
the mean scores, only correlation coefficients with stroke severity and impairment
on daily living activities scales. EQ-5D showed good correlation with SF-6D in the
RA study and with NIH Stroke Scale and modified Barthel Index in the stroke study.
Adequate convergent validity between EQ-5D and Zarit Caregiver Burden Interview
was observed among caregivers of stroke patients. CONCLUSIONS: Although the
EQ-5D is the most widely used generic preference-based measure of health-related
quality of life, studies reporting results for Brazilian samples are still scarce. Nor-
mative reference data for the general population are not available in the published
literature which makes interpreting disease-specific scores a complex task.
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OBJECTIVES: Thailand’s top 5 burden of diseases in 2004 (based on the protocol of
global burden of diseases (GBD) 2004) were HIV/AIDS, traffic accident, stroke, dia-
betes mellitus, and liver cancer, accounting for 947, 718, 652, 474, 407 Disability-
Adjusted Life Years(DALYs) per 1000 population, respectively. The technique used
by GBD to calculate the disability weight (DW) is based on an expert panel sum-
mary. However, this study measured DW directly from the patients and compared
the results. METHODS: The cross-sectional observational multicenter hospital
study was conducted in 2008-2009. The 2,695 sampling patients were selected
based on epidemiologic disease data from outpatient, inpatient and primary-care
unit in 5 major regional hospitals throughout Thailand. Selected patients were
allocated in the quota slot and completed the EQ-5D questionnaires with their
capabilities. The EQ-5D states were converted to utility weight (UW) using the Thai
preference method and then changed into DW with linear regression function to
then compare DALYs directly to the GBD result. RESULTS: Of 2695 patients, 56.99%
are male, and the age is between 1 to 100 years old. The quality of life was calcu-
lated to DW with: DW 0.688 (-0.688 x UW). The new DW differs from GBD weight
from -47.21 to 53.27 percent and these changes will affect the YLD and change the
DALYs -2.83 to 4.84%. CONCLUSIONS: The new DW from the diseases and their
complications differ from the GBD weight. This technique has the tendency to
produce more DW that GBD’s. To establish the burden of diseases, we use the
quality of life to reflect the true disability. The limitation that we have to improve is
the way to calculate the disability weight from EQ-5D for the best prediction.
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OBJECTIVES: In economic evaluations of health care interventions, outcomes are
often expressed in terms of Quality-Adjusted Life-Years (QALYs). Deriving QALY
weights, operationalized as preferences for health states, requires important nor-
mative choices. One important choice is the question whose preferences we wish
to capture. Currently, preferences are commonly derived from the general public,
rather than from actual patients. This choice, which has large consequences on
final outcomes of economic evaluations, is increasingly topic of debate. In the
current study, arguments for and against public preferences are discussed and
alternatives are suggested. METHODS: We highlight and critically assess the dif-
ferent viewpoints put forward in the health economic literature regarding the pub-
lic and patient perspective. Patient preferences are considered to reflect true pa-
tient experiences, but are troublesome because preference values elicited from
patients are ‘unusually’ high due to adaptation. Public preferences are argued to be
less sensitive to adaptation, but are troublesome because they do not adequately
forecast experience. RESULTS: The arguments put forward in the literature do not
provide straightforward support for assessing outcomes QALY weights derived the
general public. The exclusion of patient values in public decision-making is not
sufficiently argued. With patient preferences life saving interventions are likely to
become more cost-effective. CONCLUSIONS: Arguments for and against both po-
sitions represent different normative positions regarding the appropriate measure
of outcome in health care decisions. To date, the debate seems to have focused on
the question which of the two would be most appropriate. However, it seems
unclear why such a dichotomy would be necessary or, in fact, useful. Both public
and patient preferences appear to be important sources of information for the
allocation of health care resources in society. Perhaps the question should be how
to intelligently combine the two.
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OBJECTIVES: To assess the health status and health related quality of life among
rural population residing in coastal region of South India. METHODS: Randomly
selected population attending health awareness camp in rural village of South
India were recruited for the study. Kannada version of EQ-5D5L questionnaire was
used to assess the health related quality of life. Both descriptive and VAS scores
were used for assessment. The population recruited was having the age 18 years
and75 years having the family history of either diabetes, CVD or both. RESULTS:
A total of 126 patients were recruited with the meanSD age of 45.9513.44. The
descriptive scores ranging between minimum 1 and maximum 5 for different
health related quality of life indicators were, mobility score 2.110.88 (meanSD),
self-care score 1.550.83, activity score 2.070.94, pain score 2.380.86 and anxiety
score of 1.961.01. Among the different health states, 11,121 health state was
found as more common (mode). The VAS score found to be 67.5614.64.
CONCLUSIONS: There was considerable impact of pain and activity on the health
related quality of life among rural coastal population in south India who had the
family history of diabetes, CVD or both. There is a need to study the risk factors and
other quality of life indicators among the rural costal population in India.
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OBJECTIVES: Estrogen plus progestin therapies (EPT) represent the current stan-
dard of care for postmenopausal women with a uterus for the treatment of symp-
toms associated with menopause. While successfully treating climacteric symp-
toms, the presence of progestin is necessary to prevent endometrial proliferation.
Progestins contained in EPT are associated with side effects such as breast pain/
tenderness and vaginal spotting/bleeding. The objective of this study was to con-
duct qualitative interviews with menopausal women to better understand the pa-
tient experience of breast pain and vaginal bleeding symptoms associated with
EPT, and the language patients use to describe them, to inform the development of
new measurement tools for these symptoms. METHODS: Fifty-nine postmeno-
pausal women in the USA (n14), China (n15), Mexico (n15) and Italy (n15)
(aged 40-63) taking EPT and experiencing breast pain and/or vaginal bleeding/spot-
ting (47/59 were experiencing both) participated in in-depth interviews concerning
their experiences of EPT and impact on quality of life. Thematic analysis was con-
ducted to identify concepts describing the experiences of the participants using
Atlas Ti. RESULTS: In all 4 countries, breast sensations experienced while taking
EPT were described as ‘pain and tenderness’, ‘feeling swollen’ and ‘sensitivity’ to
touch or contact. Vaginal bleeding and spotting were commonly described in terms
of frequency, volume, colour and consistency. Frequency of both symptoms ranged
from ‘daily’ to ‘occasionally’. Both symptoms impacted on psychological well-be-
ing, activities of daily living and sex life. Items for new measurement tools were
developed using this qualitative data with clinical input from experts in
menopause. CONCLUSIONS: In-depth interviews with a geographically diverse
sample elicited common descriptors for the symptoms of breast pain and vaginal
bleeding and allowed items to be developed that are applicable across cultures,
conceptually consistent and easily translated. Accurately capturing descriptors
used by patients is critical to ensure new outcome tools have content validity and
cross-cultural reliability.
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